Andrew Mark Rendle Dutton Insider Profile
4 Followers
Andrew Mark Rendle Dutton, Director at Australian Clinical Labs Ltd, holds 81.90K shares in Australian Clinical Labs Ltd (Ticker: AU:ACL).
Andrew Mark Rendle Dutton's Trading History
| ACLAustralian Clinical Labs Ltd | Apr 28, 2022 | Director | Uninformative Buy | 9.60K | AU$274.35K | |||||||||||||||
AU:ACL Insider Shares: 81.90K (4.06%) Andrew Mark Rendle Dutton has not reported any informative transactions for AU:ACL, therefore, performance cannot be measured.
| ||||||||||||||||||||
You May Also Like
Andrew Mark Rendle Dutton insider profile FAQ
What stocks does Andrew Mark Rendle Dutton hold?
Andrew Mark Rendle Dutton holds: AU:ACL stocks.
What was Andrew Mark Rendle Dutton’s latest transaction?
Andrew Mark Rendle Dutton’s latest transaction was an Uninformative Buy of AU$9.60K.
What is Andrew Mark Rendle Dutton's role in Australian Clinical Labs Ltd?
Andrew Mark Rendle Dutton's role in Australian Clinical Labs Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
